XML 78 R59.htm IDEA: XBRL DOCUMENT v3.20.4
Intangible Assets (Narrative) (Details) - USD ($)
shares in Thousands
1 Months Ended 12 Months Ended
Nov. 30, 2018
Nov. 30, 2016
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Acquired Finite-Lived Intangible Assets [Line Items]          
Goodwill     $ 882,000 $ 882,000  
Other revenue, potential upfront payment related to product sales     4,800,000    
Payments to acquire businesses     0 5,000,000 $ 20,000,000
Additions to intangible assets     1,973,110 772,944 3,819,486
Amortization of intangible assets     4,434,120 4,134,557 $ 2,769,466
Product and License Rights          
Acquired Finite-Lived Intangible Assets [Line Items]          
Intangible assets, gross     38,543,542 37,400,742  
Patents          
Acquired Finite-Lived Intangible Assets [Line Items]          
Intangible assets, gross     10,306,922 9,882,511  
Additions to intangible assets     500,000 $ 700,000  
Methotrexate          
Acquired Finite-Lived Intangible Assets [Line Items]          
Payments to acquire businesses   $ 100,000      
Stock issued during period, acquisitions     900,000    
Intellectual property amortizable intangible assets     2,800,000    
Methotrexate | Nordic          
Acquired Finite-Lived Intangible Assets [Line Items]          
Stock issued during period, acquisitions     1,000,000.0    
Methotrexate | Restricted Stock          
Acquired Finite-Lived Intangible Assets [Line Items]          
Stock issued during period, acquisitions (in shares)   180      
VIBATIV          
Acquired Finite-Lived Intangible Assets [Line Items]          
Goodwill $ 882,000        
Payments to acquire businesses 20,000,000.0   20,000,000    
Intellectual property amortizable intangible assets $ 11,750,000        
Increase in goodwill     $ 100,000